From genetics and epigenetics to the future of precision treatment for obesity

Gastroenterology Report

Volumn 5, Issue 4, 2017, Pages 266-270

  Sun, Xulong ^a   Li, Pengzhou ^a   Yang, Xiangwu ^a   Li, Weizheng ^a   Qiu, Xianjie ^a   Zhu, Shaihong ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Bariatric surgery; Epigenetics; Genetics; Morbid obesity

Indexed keywords

LIRAGLUTIDE; LORCASERIN; PHENTERMINE PLUS TOPIRAMATE; TETRAHYDROLIPSTATIN;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CLINICAL OUTCOME; DIETARY INTAKE; DISEASE ASSOCIATION; EPIGENETICS; GASTRIC BANDING; GENETIC RISK; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HEREDITY; HUMAN; LAPAROSCOPIC SLEEVE GASTRECTOMY; LONG TERM CARE; NUTRITION; OBESITY; PERSONALIZED MEDICINE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; ROUX-EN-Y GASTRIC BYPASS; TREATMENT RESPONSE; WAIST CIRCUMFERENCE;

EID: 85044933851     PISSN: None     EISSN: 20520034     Source Type: Journal    
DOI: 10.1093/gastro/gox033     Document Type: Review

References (54)

1. de Luis DA, Pacheco D, Izaola O et al. Early clinical and surgical results of biliopancreatic diversion. Obes Surg 2005;15:799-802.
2. Hsu LK, Benotti PN, Dwyer J et al. Nonsurgical factors that influence the outcome of bariatric surgery: a review. Psychosom Med 1998;60:338-46.
3. Eldar S, Heneghan HM, Brethauer SA, Schauer PR. Bariatric surgery for treatment of obesity. Int J Obes (Lond) 2011;35 Suppl 3:227-41.
4. Rao KR, Lal N, Giridharan NV. Genetic & epigenetic approach to human obesity. Indian J Med Res 2014;140:589-603.
5. Hatoum IJ, Stein HK, Merrifield BF, Kaplan LM. Capacity for Physical Activity Predicts Weight Loss After Roux-en-Y Gastric Bypass. Obesity 2009;17:92-99.
6. Hunt SC, Hasstedt SJ, Xin Y et al. Polymorphisms in the NPY2R Gene Show Significant Associations With BMI That Are Additive to FTO, MC4R, and NPFFR2 Gene Effects. Obesity 2011;19:2241-47.
7. Wheeler E, Huang N, Bochukova EG et al. Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nat Genet 2013;45:513-17.
8. Amin N, Ramirez FR, Hofman A et al. Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010;42:937-48.
9. Wen W, Cho YS, ZhengWet al. Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet 2012;44:307-11.
10. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33 suppl:245-54.
11. Stöger R. Epigenetics and obesity. Pharmacogenomics 2008;9: 1851-60.
12. Dick KJ, Nelson CP, Tsaprouni L et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet 2014;383: 1990-98.
13. Feinberg AP, Irizarry RA, Fradin D et al. Personalized Epigenomic Signatures That Are Stable Over Time and Covary with Body Mass Index. Sci Transl Med 2010;2:49ra67.
14. Zhao J, Goldberg J, Vaccarino V. Promoter methylation of serotonin transporter gene is associated with obesity measures: a monozygotic twin study. Int J Obes (Lond) 2012;37: 140-45.
15. Mckay JA, Mathers JC. Diet induced epigenetic changes and their implications for health. Acta Physiol 2011;202:103-18.
16. Choi SW, Friso S, Ghandour H et al. Vitamin B-12 deficiency induces anomalies of base substitution and methylation in the DNA of rat colonic epithelium. J Nutr 2004;134:750-55.
17. Brunaud L, Alberto JM, Ayav A et al. Vitamin B12 is a strong determinant of low methionine synthase activity and DNA hypomethylation in gastrectomized rats. Digestion 2003;68: 133-40.
18. Steemburgo T, Azevedo MJ, Gross JL et al. The rs9939609 polymorphism in the FTO gene is associated with fat and fibre intakes in patients with type 2 diabetes. J Nutrigenet Nutrigenomics 2013;6:97-106.
19. Gómez ML. [Sugar-sweetened beverages and genetic risk of obesity]. Revista Cl?nica Espan~ola 2013;213:163.
20. Lee I, Djoussé L, Sesso HD et al. Physical activity and weight gain prevention. JAMA 2010;303:1173-79.
21. Ruiz JR, Labayen I, Ortega FB et al. Attenuation of the effect of the FTO rs9939609 polymorphism on total and central body fat by physical activity in adolescents: the HELENA study. Arch Pediatr Adolesc Med 2010;164:328-33.
22. Richardson AS, North KE, Graff M et al. Moderate to vigorous physical activity interactions with genetic variants and body mass index in a large US ethnically diverse cohort. Pediatr Obes 2013;9:e35-e46.
23. Kilpeläinen TO, Qi L, Brage S et al. Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218, 166 Adults and 19, 268 Children. PLoS Med 2011;8:e1001116.
24. Loos RJ, Rankinen T, Tremblay A et al. Melanocortin-4 receptor gene and physical activity in the Québec Family Study. Int J Obes (Lond) 2005;29:420-28.
25. Cai G, Cole SA, Butte N, Bacino C, Diego V, Tan K et al. A Quantitative Trait Locus on Chromosome 18q for Physical Activity and Dietary Intake in Hispanic Children. Obesity 2006; 14: 1596-604.
26. Solas M, Milagro FI, Martinez-Urbistondo D et al. Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches. Trends Pharmacol Sci 2016;37:575-93.
27. Sesti G, Perego L, Cardellini M et al. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J Clin Endocrinol Metab 2005;90:5064-69.
28. Wang X, Zheng CZ, Chang XS et al. Laparoscopic adjustable gastric banding: a report of 228 cases. Gastroenterol Rep (Oxf) 2013;1:144-48.
29. Poitou C, Lacorte JM, Coupaye M et al. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes Surg 2005; 15:11-23.
30. Sarzynski MA, Jacobson P, Rankinen T et al. Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes (Lond) 2011;35:676-83.
31. Chen HH, Lee WJ, Wang W et al. Ala55Val polymorphism on UCP2 gene predicts greater weight loss in morbidly obese patients undergoing gastric banding. Obes Surg 2007;17:926-33.
32. Maggard MA, Shugarman LR, Suttorp M et al. Meta-Analysis: Surgical Treatment of Obesity. Ann InternMed 2005;142:547-59.
33. Still CD, Wood GC, Xin C et al. High Allelic Burden of Four Obesity SNPs Is AssociatedWith PoorerWeight Loss Outcomes Following Gastric Bypass Surgery. Obesity 2011;19:1676-83.
34. Mirshahi UL, Still CD, Masker KK et al. The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery. J Clin Endocrinol Metab 2011; 96:2088-96.
35. Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 2000;10:514-23.
36. Brethauer SA, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis 2009;5:469-75.
37. Dogan M, Tugmen C, Kebapci E et al. Effective weight control and normalization of metabolic parameters after laparoscopic sleeve gastrectomy: a single center experience. Hepatogastroenterology 2013;60:368-71.
38. Shanti H, Obeidat F. The impact of family members on weight loss after sleeve gastrectomy. Surg Obes Relat Dis 2016;12: 1499-503.
39. Balasar Ö. The effect of rs9939609 FTO gene polymorphism on weight loss after laparoscopic sleeve gastrectomy. Surg Endoscopy 2016;30:121-25.
40. Matsuo T, Nakata Y, Hotta K, Tanaka K. The FTO genotype as a useful predictor of body weight maintenance: initial data froma 5-year follow-up study. Metabolism 2014;63: 912-17.
41. Liou TH, Chen HH, Wang W et al. ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients. Obes Surg 2011;21: 1758-65.
42. Luis DAD, Aller R, Conde R et al. Effects of RS9939609 gene variant in FTO gene on weight loss and cardiovascular risk factors after biliopancreatic diversion surgery. J Gastrointest Surg 2012;16:1194-98.
43. Scopinaro N, Adami GF, Marinari GM et al. Biliopancreatic diversion. World J Surg 1998;22:936-46.
44. de Luis DA, Aller R, Izaola O et al. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary to two hypocaloric diets: A randomized clinical trial. Diabetes Res Clin Pract 2008;82:113-18.
45. de Luis DA, Pacheco D, Aller R et al. Influence of G308A polymorphism of tumor necrosis factor alpha gene on surgical results of biliopancreatic diversion. Obes Surg 2010;20: 221-25.
46. de Luis DA, Pacheco D, Aller R et al. Influence of-55CT polymorphism of UCP3 gene on surgical results of biliopancreatic diversion. Obes Surg 2008;20:895-99.
47. de Luis DA, Aller R, González Sagrado M et al. Influence of Lys656asn polymorphism of leptin receptor gene on surgical results of biliopancreatic diversion. J Gastrointest Surg 2010;14: 899-903.
48. de Luis DA, Pacheco D, Aller R, Izaola O. Role of the rs6923761 gene variant in glucagon-like peptide 1 receptor gene on cardiovascular risk factors and weight loss after biliopancreatic diversion surgery. Ann Nutr Metabol 2014;65:259-63.
49. Hatoum IJ, Greenawalt DM, Cotsapas C et al. Heritability of the weight loss response to gastric bypass surgery. J Clin Endocrinol Metab 2011;96:1630-33.
50. Hatoum I, Greenawalt D, Cotsapas C et al. Weight loss after gastric bypass is associated with a variant at 15q26 1. Am J Hum Genet 2013;92:827-34.
51. Rinella ES, Still C, Shao Y et al. Genome-wide association of single-nucleotide polymorphisms with weight loss outcomes after Roux-en-Y gastric bypass surgery. J Clin Endocrinol Metab 2013;98:1131-36.
52. Rasmussen-Torvik LJ, Baldridge AS, Pacheco JA et al. rs4771122 Predicts Multiple Measures of Long-Term Weight Loss After Bariatric Surgery. Obes Surg 2015;25:2225-29.
53. Dima D, Breen G. Polygenic risk scores in imaging genetics: Usefulness and applications. J Psychopharmacol 2015;29: 867-71.
54. Bandstein M, Voisin S, Nilsson EK et al. A genetic risk score is associated with weight loss following Roux-en-Y gastric bypass surgery. Obes Surg 2016;29:2183-89.